Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
- PMID: 1559293
- DOI: 10.1111/j.1365-2265.1992.tb02909.x
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
Abstract
Objective: Obese women with polycystic ovary syndrome have a greater frequency of menstrual disturbance and of hirsutism than lean women with the syndrome. Initial studies have demonstrated a marked improvement in endocrine function following a short-term, very low calorie diet. The purpose of this study was to examine the effect of long-term calorie restriction on clinical as well as biochemical abnormalities in obese women with polycystic ovary syndrome.
Design: We performed a within-group comparison of clinical and biochemical indices before and during dietary treatment.
Patients: Twenty-four obese women with polycystic ovary syndrome (mean weight 91.5 (SD 14.7) kg) were scheduled for treatment for 6-7 months with a 1000 kcal, low fat diet. Nineteen of the 24 had menstrual disturbances, 12 had infertility and 19 were hirsute.
Measurements and results: Thirteen subjects lost more than 5% of their starting weight (range 5.9-22%). In this group there was no significant change in gonadotrophin or total serum testosterone levels but there was a marked increase in concentrations of sex hormone-binding globulin (pretreatment: 23.6 (9.5); post-treatment 36.3 (11.8) nmol/l, P = 0.002) and a reciprocal change in free testosterone levels (77 (26) vs 53 (21) pmol/l, P = 0.009). These changes were accompanied by a reduction in fasting serum insulin levels (median (range) 11.2 (5.2-32) vs 2.3 (0.1-13.8) mU/l, P = 0.018) and the insulin response to 75 g oral glucose. There were no significant changes in these indices in the group who lost less than 5% of their initial body weight. Of the 13 women who lost greater than 5% of their pretreatment weight, 11 had menstrual dysfunction. Amongst these women, nine of 11 showed an improvement in reproductive function, i.e. they either conceived (five) or experienced a more regular menstrual pattern. There was a reduction in hirsutism in 40% of the women in this group. By contrast, in the group who lost less than 5% of their initial weight, only one of the eight with menstrual disturbances noted an improvement in reproductive function and none had a significant reduction in hirsutism.
Conclusions: These data indicate that moderate weight loss during long-term calorie restriction is associated with a marked clinical improvement which reflects the reduction in insulin concentrations and reciprocal changes in SHBG. The improvement in menstrual function and fertility may therefore be consequent upon an increase in insulin sensitivity which, directly or indirectly, affects ovarian function.
Similar articles
-
The role of nutrition and insulin in the regulation of sex hormone binding globulin.J Steroid Biochem Mol Biol. 1991 Nov;39(5B):835-8. doi: 10.1016/0960-0760(91)90033-2. J Steroid Biochem Mol Biol. 1991. PMID: 1954173
-
Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome.Eur J Obstet Gynecol Reprod Biol. 2005 Mar 1;119(1):87-93. doi: 10.1016/j.ejogrb.2004.06.043. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 15734091
-
Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction.Clin Endocrinol (Oxf). 1993 Sep;39(3):363-7. doi: 10.1111/j.1365-2265.1993.tb02378.x. Clin Endocrinol (Oxf). 1993. PMID: 7693380
-
Sex hormone-binding globulin and female reproductive function.J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):529-31. doi: 10.1016/0960-0760(95)00108-c. J Steroid Biochem Mol Biol. 1995. PMID: 7626505 Review.
-
Polycystic ovary syndrome: an endocrine and metabolic disease.Gynecol Endocrinol. 2000 Oct;14(5):392-5. doi: 10.3109/09513590009167709. Gynecol Endocrinol. 2000. PMID: 11109980 Review.
Cited by
-
Role of metformin in the management of polycystic ovary syndrome.Ther Adv Endocrinol Metab. 2010 Jun;1(3):117-28. doi: 10.1177/2042018810380215. Ther Adv Endocrinol Metab. 2010. PMID: 23148156 Free PMC article.
-
Effects of intraperitoneal insulin versus subcutaneous insulin administration on sex hormone-binding globulin concentrations in patients with type 1 diabetes mellitus.Endocr Connect. 2016 May;5(3):136-42. doi: 10.1530/EC-16-0006. Endocr Connect. 2016. PMID: 27287189 Free PMC article.
-
Longterm management of Polycystic Ovarian Syndrome (PCOS).Mol Cell Endocrinol. 2013 Jul 5;373(1-2):91-7. doi: 10.1016/j.mce.2012.10.029. Epub 2012 Dec 20. Mol Cell Endocrinol. 2013. PMID: 23261983 Free PMC article. Review.
-
The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies.J Endocrinol Invest. 1998 Oct;21(9):567-79. doi: 10.1007/BF03350782. J Endocrinol Invest. 1998. PMID: 9856411 Review.
-
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Endocr Rev. 2015 Oct;36(5):487-525. doi: 10.1210/er.2015-1018. Endocr Rev. 2015. PMID: 26426951 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
